HAE logo

Haemonetics (HAE)

Profile

Full Name

Haemonetics Corporation

Ticker Symbol

HAE

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

May 10, 1991

Indexes

Not included

Website

http://www.haemonetics.com

Employees

3023

Key Details

Price

$76.87(+0.83%)

Market cap

$3.69B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.36B(+3.95% YoY)

Annual EPS

$3.31(+44.54% YoY)

PE ratio

23.22

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $76.87
    HAE price is $76.87

    30-Day Relative Volume

    0.47
    HAE 30-day relative volume is 0.47

    Price Performance

    Price Most recent change

    +0.83%
    HAE price was up +0.83% on Jul 3, 2025

    Price YTD change

    -1.55%
    HAE price is down -1.55% since January 1st

    Price 1-year change

    -8.63%
    HAE price is down -8.63% year-on-year

    Price 3-year change

    +14.19%
    HAE price is up +14.19% over the past 3 years

    Price Range

    Price All-time high

    $142.11
    HAE price is currently -45.91% below its historical high of $142.11

    Price 3-year low

    $55.30
    HAE price is currently +39.01% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $3.69B
    HAE market capitalization is $3.69 billion

    Market cap 3-year change

    +6.89%
    HAE market capitalization is up +6.89% over the past 3 years

    Market cap All-time high

    $7.09B
    HAE market capitalization is currently -47.91% below its historical high of $7.09 billion

    Market cap sector rank

    86.9%
    HAE market capitalization is higher than 86.9% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -6.09%
    HAE shares outstanding is down -6.09% year-on-year

    Shares Outstanding 3-Year Change

    -6.39%
    HAE shares outstanding is down -6.39% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.66
    HAE beta is 0.66

    200-day SMA

    $71.99
    HAE price is currently +6.78% above its 200-day simple moving average

    50-day SMA

    $68.82
    HAE price is currently +11.70% above its 50-day simple moving average

    RSI

    73.55
    HAE 14-day relative strength index is 73.55

    Volume

    0.47
    HAE 30-day relative volume is 0.47

    ATR

    $1.61
    HAE average true range is $1.61

    10-day Historical Volatility

    16.48%
    HAE 10-day historical volatility is 16.48%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.36B
    HAE annual revenue is $1.36 billion

    Revenue Analysts estimate

    $1.31B
    HAE annual revenue is currently +3.83% higher than the consensus analysts' forecast

    Revenue 1-year change

    +3.95%
    HAE annual revenue is up +3.95% year-on-year

    Revenue Sector rank

    82.9%
    HAE annual revenue is higher than 82.9% of companies in Healthcare sector

    EPS

    EPS

    $3.31
    HAE annual earnings per share is $3.31

    EPS Analysts estimate

    $4.87
    HAE annual earnings per share is currently -32.04% lower than the consensus analysts' forecast

    EPS 1-year change

    +44.54%
    HAE annual earnings per share is up +44.54% year-on-year

    EPS Sector rank

    93.99%
    HAE annual earnings per share is higher than 93.99% of companies in Healthcare sector

    Profit

    Gross profit

    $748.96M
    HAE annual gross profit is $748.96 million

    Gross margin

    55.04%
    HAE annual gross profit margin is 55.04%

    Operating profit

    $221.82M
    HAE annual operating income is $221.82 million

    Operating margin

    14.78%
    HAE annual operating profit margin is 14.78%

    Net income

    $167.68M
    HAE annual net profit is $167.68 million

    Net margin

    12.32%
    HAE annual net profit margin is 12.32%

    Expenses

    Total expenses

    $1.16B
    HAE annual total expenses is $1.16 billion

    Operating expenses

    $547.77M
    HAE annual total operating expenses is $547.77 million

    Cost of goods sold

    $611.87M
    HAE annual cost of goods sold is $611.87 million

    Selling, general & administrative expenses

    $436.79M
    HAE annual SGA is $436.79 million

    Depreciation and amortization

    $115.59M
    HAE annual depreciation & amortization is $115.59 million

    Interest expense

    $9.75M
    HAE annual interest expense is $9.75 million

    Income tax

    $44.39M
    HAE annual income tax is $44.39 million

    EBIT & EBITDA

    EBIT

    $221.82M
    HAE annual earnings before interest & taxes is $221.82 million

    EBITDA

    $337.40M
    HAE annual EBITDA is $337.40 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $2.45B
    HAE annual total assets is $2.45 billion

    Non current assets

    $1.52B
    HAE annual long term assets is $1.52 billion

    Current assets

    $934.98M
    HAE annual total current assets is $934.98 million

    Cash and cash equivalents

    $306.76M
    HAE annual cash & cash equivalents is $306.76 million

    Accounts receivable

    $202.66M
    HAE annual accounts receivable is $202.66 million

    Inventory

    $365.14M
    HAE annual inventory is $365.14 million

    Liabilities

    Total liabilities

    $1.63B
    HAE annual total liabilities is $1.63 billion

    Long term liabilities

    $1.05B
    HAE annual total long term liabilities is $1.05 billion

    Current liabilities

    $578.11M
    HAE annual total current liabilities is $578.11 million

    Accounts payable

    $67.00M
    HAE annual accounts payable is $67.00 million

    Debt

    Total debt

    $1.22B
    HAE annual total debt is $1.22 billion

    Total debt 1-year change

    +51.62%
    HAE annual total debt is up +51.62% year-on-year

    Long term debt

    $921.23M
    HAE annual long term debt is $921.23 million

    Short term debt

    $303.56M
    HAE annual short term debt is $303.56 million

    Equity & Capital

    Shareholders equity

    $820.84M
    HAE annual stockholders equity is $820.84 million

    Book value

    $820.84M
    HAE annual book value is $820.84 million

    Retained earnings

    $352.17M
    HAE annual retained earnings is $352.17 million

    Working capital

    $356.86M
    HAE annual working capital is $356.86 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $181.72M
    HAE annual cash flow from operations is $181.72 million

    Cash from operations 1-year change

    -0.01%
    HAE annual cash flow from operations is down -0.01% year-on-year

    Cash from investing

    -$161.90M
    HAE annual cash flow from investing activities is -$161.90 million

    Cash from investing 1-year change

    +49.78%
    HAE annual cash flow from investing activities is up +49.78% year-on-year

    Cash from financing

    $108.82M
    HAE annual cash flow from financing activities is $108.82 million

    Cash from financing 1-year change

    +185.18%
    HAE annual cash flow from financing activities is up +185.18% year-on-year

    CAPEX

    CAPEX

    $39.28M
    HAE annual capital expenditures is $39.28 million

    CAPEX 1-year change

    +3.02%
    HAE annual capital expenditures is up +3.02% year-on-year

    Free Cash Flow

    Free cash flow

    $142.45M
    HAE annual free cash flow is $142.45 million

    Free cash flow 1-year change

    -0.82%
    HAE annual free cash flow is down -0.82% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    55.04%
    HAE annual gross profit margin is 55.04%

    Operating margin

    14.78%
    HAE annual operating profit margin is 14.78%

    Net margin

    12.32%
    HAE annual net profit margin is 12.32%

    ROA & ROE

    ROA

    7.22%
    HAE annual return on assets is 7.22%

    ROE

    18.83%
    HAE annual return on equity is 18.83%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    23.22
    HAE price to earnings ratio is 23.22

    PE ratio Sector rank

    46.26%
    HAE price to earnings ratio is higher than 46.26% of companies in Healthcare sector

    PB Ratio

    PB ratio

    4.50
    HAE price to book ratio is 4.50

    PB ratio Sector rank

    78.44%
    HAE price to book ratio is higher than 78.44% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.71
    HAE price to sales ratio is 2.71

    PS ratio Sector rank

    47.81%
    HAE price to sales ratio is higher than 47.81% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $4.61B
    HAE enterprise value is $4.61 billion

    Enterprise value Sector rank

    87.28%
    HAE enterprise value is higher than 87.28% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    13.67
    HAE EV/EBITDA is 13.67

    EV/EBITDA Sector rank

    87.27%
    HAE EV/EBITDA is higher than 87.27% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.62
    HAE annual current ratio is 1.62

    Quick ratio

    0.99
    HAE annual quick ratio is 0.99

    Leverage

    Debt to equity

    1.49
    HAE annual debt to equity ratio is 1.49

    Interest coverage ratio

    22.76
    HAE annual interest coverage ratio is 22.76

    Risk & Stability

    Piotroski F-Score

    6
    HAE piotroski f-score is 6

    Altman Z-Score

    2.59
    HAE altman z-score is 2.59

    Analyst ratings

    Recent major analysts updates

    May 20, 25 JMP Securities
    Market Outperform
    May 9, 25 Raymond James
    Strong Buy
    May 8, 25 Needham
    Buy
    Feb 7, 25 Raymond James
    Strong Buy
    Feb 7, 25 Needham
    Buy
    Feb 7, 25 JMP Securities
    Market Outperform
    Feb 7, 25 Barrington Research
    Outperform
    Dec 6, 24 JP Morgan
    Overweight
    Dec 4, 24 Barrington Research
    Outperform
    Dec 3, 24 Needham
    Buy

    Institutional Ownership

    Screeners with HAE included

    Mid cap stocks
    US stocks
    High Piotroski score stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Stocks with high RSI
    • What is the ticker symbol for Haemonetics?
    • Does Haemonetics pay dividends?
    • What sector is Haemonetics in?
    • What industry is Haemonetics in?
    • What country is Haemonetics based in?
    • When did Haemonetics go public?
    • Is Haemonetics in the S&P 500?
    • Is Haemonetics in the NASDAQ 100?
    • Is Haemonetics in the Dow Jones?
    • When was Haemonetics's last earnings report?
    • When does Haemonetics report earnings?
    • Should I buy Haemonetics stock now?

    What is the ticker symbol for Haemonetics?

    The ticker symbol for Haemonetics is NYSE:HAE

    Does Haemonetics pay dividends?

    No, Haemonetics does not pay dividends

    What sector is Haemonetics in?

    Haemonetics is in the Healthcare sector

    What industry is Haemonetics in?

    Haemonetics is in the Medical Devices industry

    What country is Haemonetics based in?

    Haemonetics is headquartered in United States

    When did Haemonetics go public?

    Haemonetics's initial public offering (IPO) was on May 10, 1991

    Is Haemonetics in the S&P 500?

    No, Haemonetics is not included in the S&P 500 index

    Is Haemonetics in the NASDAQ 100?

    No, Haemonetics is not included in the NASDAQ 100 index

    Is Haemonetics in the Dow Jones?

    No, Haemonetics is not included in the Dow Jones index

    When was Haemonetics's last earnings report?

    Haemonetics's most recent earnings report was on May 8, 2025

    When does Haemonetics report earnings?

    The next expected earnings date for Haemonetics is Aug 8, 2025

    Should I buy Haemonetics stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page